Meanwhile, some studies have shown that AnxA6 is downregulated in the highly malignant forms of gastric cancer [114], hepatocellular carcinomas [115], cervical cancer [116] and breast cancer [22]. This evidence concerns the gene ANXA6 and hepatocellular carcinoma.